key: cord-0833212-uuw8yxkj
authors: Cai, Yongfei; Zhang, Jun; Xiao, Tianshu; Lavine, Christy L.; Rawson, Shaun; Peng, Hanqin; Zhu, Haisun; Anand, Krishna; Tong, Pei; Gautam, Avneesh; Lu, Shen; Sterling, Sarah M.; Walsh, Richard M.; Rits-Volloch, Sophia; Lu, Jianming; Wesemann, Duane R.; Yang, Wei; Seaman, Michael S.; Chen, Bing
title: Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
date: 2021-04-14
journal: bioRxiv
DOI: 10.1101/2021.04.13.439709
sha: 8007fde52f2f6f3cedf7ba6d664a80c27c357942
doc_id: 833212
cord_uid: uuw8yxkj

Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains that continue to fuel the COVID-19 pandemic despite intensive vaccination efforts throughout the world. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Mutations in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2). The enhanced receptor engagement can account for the increased transmissibility and risk of mortality as the variant may begin to infect efficiently infect additional cell types expressing low levels of ACE2. The B.1.351 variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, rendering complete resistance to some potent neutralizing antibodies. These findings provide structural details on how the wide spread of SARS-CoV-2 enables rapid evolution to enhance viral fitness and immune evasion. They may guide intervention strategies to control the pandemic.

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1), has led to loss of human life in millions, as well as devastating socioeconomic disruptions worldwide. Although the mutation rate of the coronavirus is relatively low because of the proofreading activity of its replication machinery (2) , several variants of concern (VOCs) have emerged in different countries, including the B.1.1.7 lineage first identified in the United Kingdom, the B.1.351 lineage in South Africa and the B.1.1.28 lineage in Brazil within a period of several months (3) (4) (5) . These variants not only appear to spread more rapidly than the virus from the initial outbreak (i.e., the strain Wuhan-Hu-1; ref (1)), but also are more resistant to immunity elicited by the Wuhan-Hu-1 strain in the setting of either natural infection or vaccination (6) (7) (8) . The B.1.1.7 variant is of particularly concern because it has been reported to be significantly more deadly (9, 10) . Thus, understanding the underlying mechanisms of the increased transmissibility, risk of mortality and immune resistance of the new variants may facilitate development of intervention strategies to control the crisis.

SARS-CoV-2 is an enveloped positive-stranded RNA virus that depends on fusion of viral and target cell membranes to enter a host cell. This first key step of infection is catalyzed by the virus-encoded trimeric spike (S) protein, which is also a major surface antigen and thus an important target for development of diagnostics, vaccines and therapeutics. The S protein is synthesized as a single-chain precursor and subsequently cleaved by a furin-like protease into the receptor-binding fragment S1 and the fusion fragment S2 ( Fig. S1 ; ref (11) ). It is generally believed that binding of the viral receptor angiotensin converting enzyme 2 (ACE2) on the host cell surface to the receptor-binding domain (RBD) of S1, together with a second proteolytic cleavage by a cellular serine protease TMPRSS2 or endosomal cysteine proteases cathepsins B and L (CatB/L) in S2 (S2' site; Fig. S1 ; ref (12) ), induce large conformational changes and prompt dissociation of S1 and irreversible refolding of S2 into a postfusion structure, ultimately leading to membrane fusion (13, 14) . In the prefusion conformation, S1 folds into four domains -NTD (N-terminal domain), RBD, and two CTDs (C-terminal domains), and they wrap around the prefusion structure of S2. The RBD can adopt two distinct conformations -"up" for a receptor-accessible state and "down" for a receptor-inaccessible state (15) .

Remarkable progress in structural biology of the S protein has been achieved rapidly since the early stage of the pandemic, advancing our knowledge on the SARS-CoV-2 entry process considerably (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . We have previously identified two structural elements -the FPPR (fusion peptide proximal region) and 630 loop, which appear to modulate the overall stability of the S protein, as well as the RBD conformation and thus the receptor accessibility (22, 28) .

The S protein is the centerpiece of almost all the first-generation COVID-19 vaccines, which were developed shortly after the initial outbreak using the sequence of the Wuhan-Hu-1 strain (29, 30) . Several of them have completed phase 3 trials, showing impressive protective efficacy with minimal side effects (31, 32) , and they have therefore received Emergency Use Authorization (EUA) by various regulatory agencies throughout the world. These vaccines appear to have somewhat lower efficacy against the B.1.351 variant than against its parental strain (6) (7) (8) 33) . In addition, this variant became completely resistant to many convalescent serum samples from those recovered from COVID-19 (8) . How to address genetic diversity has therefore become a high priority for developing next-generation vaccines. In this study, we have characterized the full-length S proteins from the B.1.1.7 and B.1.351 variants and determined their structures by cryoelectron microscopy (cryo-EM), providing a structural basis for understanding the molecular mechanisms of the enhanced infectivity, risk of mortality and immune evasion of these two variants.

To characterize the full-length S proteins with the sequences derived from natural isolates of the B.1.1.7 (hCoV-19/England/MILK-C504CD/2020) and B.1.351 (hCoV-19/South Africa/KRISP-EC-MDSH925100/2020) variants (Fig. S1 ), we first transfected HEK293 cells with the respective expression constructs and compared their membrane fusion activities with those of the full-length S constructs of their parental strains (Wuhan-Hu-1: D614, and its early variant with D614G substitution: G614 (34)). All S proteins expressed at comparable levels, as judged by western blot (Fig. S2A ). The cells expressing these S proteins fused efficiently with the cells transfected with a human ACE2 construct (Fig. S2B) , indicating that they are fully functional as a membrane fusogen. Consistent with our previous findings (22, 28) , the G614 and B.1.351 variant S constructs showed slightly higher fusion activity than those of the D614 and B.1.1.7

variant, but the differences diminished when the transfection level increased.

To produce the full-length S proteins, we added a C-terminal strep-tag to the B.1.1.7 and B.1.351 S (Fig. S3A ), expressed and purified these proteins under the identical conditions established for producing the D614 and G614 S trimers (22, 28) . The B.1.1.7 protein eluted in three distinct peaks representing the prefusion S trimer, the postfusion S2 trimer and the dissociated S1 monomer, respectively (22) , consistent with Coomassie-stained SDS-PAGE analysis (Fig. S3B) . Nonetheless, the prefusion trimer was still the predominant form, accounting for >70% of the total protein. Like the G614 trimer (28), B.1.351 protein eluted as a single major peak, corresponding to the prefusion S trimer ( Fig. S3B) , with no obvious peaks for dissociated S1 and S2. SDS-PAGE analysis showed that the peaks for the prefusion trimers contained primarily the cleaved S1/S2 complex for both the proteins with the cleavage level moderately higher for B.1.351 S than for B.1.1.7 S. These results indicate that the B.1.351 and G614 S proteins have almost identical biochemical properties, while the B.1.1.7 S trimer is slightly less stable.

To assess antigenic properties of the purified prefusion S trimers from the new variants, we first measured by bio-layer interferometry (BLI) their binding to recombinant soluble ACE2 and S-directed monoclonal antibodies isolated from COVID-19 convalescent individuals. These antibodies target various epitopic regions on the S trimer, as defined by clusters of competing antibodies and designated RBD-1, RBD-2, RBD-3, NTD-1, NTD-2 and S2 ( Fig. S4A ; ref (35) ). All but the last two clusters contain neutralizing antibodies. The B.1.1.7 variant bound substantially more strongly to the receptor than did its G614 parent, regardless of the oligomeric state of ACE2 (Figs. 1 and S4B; Table S1 ).

The B.1.351 protein had higher affinity for monomeric ACE2, but slightly lower affinity for dimeric ACE2, than did the G614 trimer. In both cases, affinity for ACE2 of the Table S1 ). In contrast, the B.1.351 variant completely lost binding to the two RBD-2 antibodies, 32B6 and 12A2, as well as to the two NTD-1 antibodies, 12C9 and 83B6, while the affinities for the rest of the antibodies were the same as those of the G614 trimer. An RBD-3 antibody, 63C7, which recognizes the RBD-up conformation, bound more strongly to the B.1.1.7 trimer than to the G614 and B.1.351 proteins, for which it had affinities nearly equal to each other. To rule out potential artifacts associated with the proteins purified in detergent, we tested by flow cytometry binding of these antibodies and of a designed trimeric ACE2 construct to the S proteins expressed on the cell surfaces. As shown in Fig. S5 , the binding results with the membrane-bound S trimers are largely in agreement with the data measured by BLI. In particular, the B.1.1.7 S had a substantially higher affinity for the trimeric ACE2 than did the G614 and B.1.351 proteins.

We also assessed the neutralization potency of the antibodies and the trimeric ACE2 construct in blocking infection of these variants in an HIV-based pseudovirus assay. As summarized in Table S2 , for most antibodies, the neutralization potency strictly correlated with their binding affinity for either the membrane-bound or purified S proteins. 81D6 and 163E6 recognize two non-neutralizing epitopes, located in the NTD and S2, respectively, and they did not neutralize any of the pseudoviruses. We note that Table S3 ).

As expected, the overall architectures of the full-length S proteins from the new variants are very similar to that of the G614 S trimer in the corresponding conformation (Figs. S10 and S11; ref (28)). In the closed, three RBD-down structure, the four domains of S1 --NTD, RBD, CTD1 and CTD2 --cap the almost invariant prefusion S2 trimer. In the one RBD-up conformation, the RBD position has no effect on the central core region of S2, but two NTDs, the immediately adjacent one and the one from the same protomer, shift For the B.1.1.7 S trimer, most of the particles used for refinement were in the RBD-up conformation ( Fig. 2A-E) . We have proposed that the FPPR and 630 loop modulate the stability and fusogenic structural rearrangements of the S protein (22, 28) . In the closed conformation of the B.1.1.7 trimer, all three FPPR and three 630 loops are disordered ( Fig. 2F) , which otherwise would help clamp down the RBDs. This observation can explain why the B.1.1.7 trimer prefers an RBD-up conformation, unlike its parental stain, the G614 variant. In the one RBD-up conformation, one 630 loop on the opposite side of the shifted RBD becomes fully structured, inserting between neighboring NTD and CTDs in the same configuration found in the G614 trimer (28) . The second 630 loop is partially ordered, while the third one remains disordered. A similar pattern is found for three FPPRs, although the structured FPPR adopts a conformation distinct from the one seen in our previous structures of the full-length S proteins (22, 28) . Overall, the arrangement of these structural elements appears to stabilize the cleaved S trimer and to prevent the premature dissociation of S1 in the one RBD-up conformation. The three one RBD-up structures differ only by the degree to which the "up" RBD and the adjacent NTD of its neighboring protomer shift away from the central threefold axis (Fig. S12A ). We have suggested that the two RBD-up conformation might be unstable (22, 28) , leading to S1 dissociation and irreversible refolding of S2. If this suggestion is valid, the small class of the two RBD-up particles probably contains mainly uncleaved S trimers. (28)).

We superposed the structures of the B.1.1.7 trimer onto the G614 trimer in the closed conformation aligning them by the S2 structure (Fig. 3A) , and detected an outward rotation of all three S1 subunits, leading to a slightly more open conformation than that of the G614 trimer. This rotation in the B.1.1.7 variant widened the gap between the NTD and the CTDs of the same protomer (Fig. S12B ). In the G614 trimer, this gap accommodates the ordered 630 loop that reinforces CTD2 and prevents S1 shedding (28) .

Thus, the widened gap in the variant loosens the grip on the 630 loop, accounting for the absence of ordered features in this part of the B.1.1.7 map. There are two mutations that may be responsible for these structural differences. First, Ala570 in CTD1 normally packs against one side of the FPPR in the G614 trimer (Fig. 3B) . The A570D mutation, with a larger side chain, may weaken the packing and destabilize the FPPR, which is not do not produce any major structural rearrangements (Fig. 4B) . The most striking differences are in the NTD, which contains three point mutations (L18F, D80A and D215G) and a three-residue deletion (L242del, A243del and L244del). The L18F and D80A lead to reconfiguration of the N-terminal segment despite the disulfide between Cys16 and Cys136 that partly anchors the N-terminal peptide (Fig. 4C ). D215G appears to have the least structural impact since Asp215 is a solvent-exposed residue that may compensate for the surface charge from the neighboring, well-exposed Arg214.

The most consequential changes are probably from the triple residue deletion, as these nonpolar residues, located on the edge of the NTD core structure formed by four stacking β-sheets, are replaced with polar residues His245-Arg246-Ser247. This replacement causes a shift of the nearby loop 144-155 and must also reconfigure the adjacent disorder loop (residues 246-260), both of which form part of the neutralizing epitopes (38) . antibody that has part of its footprint in this region. Additional mutation A701V is located in surface-exposed region of S2 and caused minimal structural changes (Fig.   S13D ). It is difficult to predict the impact of this mutation since the functional role of this segment is unclear.

Transmissibility and immune evasion are independent selective forces driving emergence of viral genetic diversity. The changes of most concern in the SARS-CoV-2 S protein would be those that simultaneously enhance transmission, augment disease severity, and evade immune recognition in previously exposed hosts. Our data suggest that the most problematic combination of such mutations is not yet present in the existing variants examined here.

In the B.1.1.7 virus, mutations A570D and S982A lead to an outward shift of the CTD1 away from the threefold axis, thereby relaxing the two key structural elements, the FPPR and 630 loop, which in the parental strain help retain the RBD in its "down" position. The mutations effectively increase the frequency with which the S trimer samples the one RBD-up conformation and thus more effectively presents the receptor binding motif (RBM) to ACE2 on the host cells. Once one RBD flips up, the fully or partially ordered 630 loops of the neighboring protomers stabilize the CTD2, which folds together with the N-terminal segment of S2, and thus prevent the premature dissociation of S1 and inactivation of the functional spike. The N501Y mutation in the ACE2 binding site of the RBD also increases the affinity of that domain for both the monomeric and dimeric ACE2 proteins, probably because of hydrophobic interaction of Tyr501 with Tyr41 of ACE2 (39), as well as a possible cation-π interaction with ACE2 Lys353 (Fig. S15) Residue 501 is outside of the major neutralizing epitope clusters in the RBD (Fig. S4) , and its mutation from asparagine to tyrosine does not cause any widespread conformational shifts. The N501Y mutation has therefore brought only minimal changes in the sensitivity of the B.1.1.7 variant to the potently neutralizing antibodies that bind the RBD (Table S1 and S2). In addition, the mutations in the NTD caused no major structural rearrangements, consistent with potent neutralization against the B.1.1.7 virus by NTD-directed neutralizing antibodies. Thus, the B.1.1.7 variant, while posing a threat, as documented, to unvaccinated or virus-naïve individuals, may be a less serious concern for those with infection-or vaccine-elicited immunity to the Wu_Hu-1 strain (33).

In the B.1.351 virus, the S protein largely retains the structure of the G614 trimer with almost identical biochemical stability. Mutations N501Y, K417N and E484K in the RBD have not led to any major structural changes, but the loss of salt bridges between K417 and ACE2 Asp30 and Glu484 and ACE2 Lys31 more or less cancels the increased receptor affinity imparted by N501Y (Fig. S15) . The mutations at residues 417 and 484 are probably responsible, however, for loss of detectable binding and neutralization by antibodies that target the RBD-2 epitopes (Fig. S4A) . Moreover, the accompanying mutations in the NTD remodel the antigenic surface of the domain, greatly reducing the potency of neutralizing antibodies that target NTD-1 epitopes. In particular, deletion of three consecutive residues in a β-strand forming the core structure of the NTD is clearly 

We thank the SBGrid team for technical assistance, K. Arnett for support and advice on the BLI experiments, and S. Harrison and A. Carfi for critical reading of the manuscript. 

Expression and purification of the full-length S proteins were carried out as previously described (22) . The monomeric ACE2 or dimeric ACE2 proteins were produced as described (41) .

Briefly, Expi293F cells transfected with monomeric ACE2 or dimeric ACE2 expression construct and the supernatant of the cell culture was collected. The monomeric ACE2 protein was purified by affinity chromatography using Ni Sepharose excel (Cytiva Life Sciences, Marlborough, MA), followed by gel filtration chromatography. The dimeric ACE2 protein was purified by GammaBind Plus Sepharose beads (GE Healthcare), followed gel filtration chromatography on a Superdex 200 Increase 10/300 GL column.

All the monoclonal antibodies were produced as described (35) .

Western blot was performed using an anti-SARS-COV-2 S antibody following a protocol described previously (42) . Briefly, full-length S protein samples were prepared from cell pellets and resolved in 4-15% Mini-Protean TGX gel (Bio-Rad, Hercules, CA) and 

The cell-cell fusion assay, based on the α-complementation of E. coli β-galactosidase, was conducted to quantify the fusion activity mediated by SARS-CoV2 S protein, as described (22) . Briefly, various amount of the full-length SARS-CoV2 (D614, G614, UK and South Afirca) S construct (0.025-10 µg) and the α fragment of E. coli β-galactosidase construct (10 µg), or the full-length ACE2 construct (10 µg) together with the ω fragment of E. coli β-galactosidase construct (10 µg), were transfected to HEK293T cells using Polyethylenimine (PEI) (80 µg). After a 24-hour incubation at 37°C, the cells were detached using PBS buffer with 5mM EDTA and resuspended in complete DMEM medium. 50 µl S-expressing cells (1.0x10 6 cells/ml) were mixed with 50 µl ACE2expressing cells (1.0x10 6 cells/ml) to allow the cell-cell fusion proceed at 37 °C for 2 hours. Cell-cell fusion activity was quantified using a chemiluminescent assay system, Gal-Screen (Applied Biosystems, Foster City, CA), following the standard protocol recommended by the manufacturer. The substrate was added to the mixture of the cells and allowed to react for 90 minutes in dark at room temperature. The luminescence signal was recorded with a Synergy Neo plate reader (Biotek, Winooski, VT).

Binding of monomeric or dimeric ACE2 to the full-length Spike protein of each variant was measured using an Octet RED384 system (ForteBio, Fremont, CA), following the protocol described previously (41) . Briefly, the full-length S protein was immobilized to and transferred to 96-well plate. The sensors were dipped in the wells containing the Spike protein solutions for 5 minutes to measure the association rate, followed with 10 minutes in the wells of the running buffer to measure the dissociation rate. Control sensors with no Spike protein or antibody were also dipped in the ACE2 or Spike protein solutions and the running buffer as references. Recorded sensorgrams with background subtracted from the references were analyzed using the software Octet Data Analysis HT Version 11.1 (ForteBio). Binding kinetics was evaluated using a 1:1 Langmuir model except for dimeric ACE2 and antibodies 32B6 and 12A2, which were analyzed by a bivalent binding model. 

To prepare cryo grids, 3.5 µl of the freshly purified sample from the peak fraction in DDM at ~2.0 mg/ml for the B. 

Drift correction for cryo-EM images was performed using MotionCor2 (44) , and contrast transfer function (CTF) was estimated by CTFFIND4 (45) using motioncorrected sums without dose-weighting. Motion corrected sums with dose-weighting were used for all other image processing. RELION3.0.8 and crYOLO (46) were used for particle picking, 2D classification, 3D classification and refinement procedure. For the B.1.1.7 sample, approximately 3,000 particles were manually picked for each protein sample and subjected to 2D classification to generate the templates for automatic particle picking. After manual inspection of auto-picked particles, a total of 2,325,106 particles were extracted from 27,950 images. The selected particles were subjected to 2D classification, giving a total of 877,530 good particles. A lowresolution negative-stain reconstruction of the D614 S trimer (22) was low-pass filtered to 30Å resolution and used as an initial model for 3D classification with C1 symmetry. Three major classes showed clear structural features were subjected to another round of 3D classification with C1 symmetry, giving another three major classes. These three classes were joined together and re-extract to do one round of 3D auto-refinement, following by CTF Refinement, Particle Polishing, and another round of 3D auto-refinement, giving a map with 271,387 particles at 3.3Å resolution. Third round of signal-subtraction 3D classification without alignment at the apex region of the S trimer were performed to further classify, produced five different major classes, representing the closed, three RBD-down conformation, three of the one RBD-up conformation and two RBD-up conformation, respectively. The five classes containing 13,919, 77,942, 7,368, 119,338, 41,138 particles, respectively, were then subjected to another round of 3D auto-refinement with C1 (one RBD-up and two RBD-up) and C3 (closed) symmetry using an overall mask, resulting in five final reconstructions at 4.0Å, 3.3Å, 4.3Å, 3.2Å and 3.1Å resolutions, respectively. Several rounds of 3D autorefinement was done for each then by adding different size of mask at the apex region to further improve the local resolution. The best map from each class was used for model building.

For the B.1.351 sample, after manual inspection of auto-picked particles, a total of 4,875,287 particles were extracted from 33,931 images. The selected particles were subjected to 2D classification, giving a total of 1,380,218 good particles. The lowresolution negative-stain reconstruction of the sample was low-pass-filtered to 40Å as an initial model for 3D classification with C1 symmetry. Two major classes with 224,988 and 301,967 particles that showed clear structural features were subjected to the second round of 3D classification with C1 symmetry. One class showing a 3-RBD down conformation with 124,042 particles was selected for auto-Refinement, giving a reconstruction at 4.2Å resolution.

Third round of signal-subtraction 3D classification without alignment at the apex region of the S trimer were performed to further classify, produced three different major classes, representing the closed, three RBD-down conformation, two of the one RBD-up conformation, respectively. The closed state classes containing 53,772 particles were then subjected to another round of 3D auto-refinement with C1 symmetry using an overall mask, resulting in final reconstruction at 4.5Å resolution.

Several rounds of 3D auto-refinement were performed by adding a different size of mask at the apex region to further improve the local resolution. The best map from each class was used for model building.

For the RBD-up class of the B.1.351 sample, data processing was primarily carried out in cryoSPARC (37) . Initially picked particles were subjected to sequential 2D Reported resolutions are based on the gold-standard Fourier shell correlation (FSC) using the 0.143 criterion. All density maps from RELION were corrected from the modulation transfer function of the K3 detector and then sharpened by applying a temperature factor that was estimated using post-processing in the program. Local resolution was determined using RELION with half-reconstructions as input maps.

The initial templates for model building used the stabilized SARS-CoV-2 S ectodomain trimer structure (PDB ID 7KRQ and PDB ID 7KRR) for both the B.1.351 and B.1.1.7 variant spike protein prefusion conformation. Several rounds of manual building were performed in Coot (47) . The maps with a resolution lower than 4.0Å were primarily modeled manually in coot and by rigid body fitting, as the local resolution of many regions is higher than 4.0Å. The model was then refined in Phenix was performed in both Phenix (real space refinement) and ISOLDE (49) , and the Phenix refinement strategy included minimization_global, local_grid_search, and adp, with rotamer, Ramachandran, and reference-model restraints, using 7KRQ and 7KRR as the reference model. The refinement statistics are summarized in Table S2 .

Structural biology applications used in this project were compiled and configured by SBGrid (50) .

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv

SARS-CoV-2 Variant Under Investigation 202012/01 has more than twofold replicative advantage. medRxiv

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv

Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization. bioRxiv

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. bioRxiv

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Structural insights into coronavirus entry

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Structural basis of receptor recognition by SARS-CoV-2

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Distinct conformational states of SARS-CoV-2 spike protein

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. bioRxiv

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Molecular Architecture of the SARS-CoV-2 Virus

The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Viral targets for vaccines against COVID-19

Novel approaches for vaccine development

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Safety and Efficacy of the BNT162b2 mRNA Covid-19

New SARS-CoV-2 Variants -Clinical, Public Health, and Vaccine Implications

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. bioRxiv

RELION: implementation of a Bayesian approach to cryo-EM structure determination

cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Cryo-EM Structures of the N501Y SARS-CoV-2 Spike Protein in Complex with ACE2 and Two Potent Neutralizing Antibodies. bioRxiv

Covid-19: The E484K mutation and the risks it poses

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein

Automated electron microscope tomography using robust prediction of specimen movements

MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy

CTFFIND4: Fast and accurate defocus estimation from electron micrographs

SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM

Features and development of Coot

PHENIX: a comprehensive Python-based system for macromolecular structure solution

ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps

Collaboration gets the most out of software

A-E) The structures of the closed prefusion conformation, three one RBD-up conformations and a two RBD-up conformation of the B.1.1.7 S trimer are shown in ribbon diagram with one protomer colored as NTD in blue, RBD in cyan, CTD1 in green, CTD2 in light green, S2 in light blue, the 630 loop in red and the FPPR in magenta. (G) and (H) The structures of the closed prefusion conformation and one RBD-up conformation of the B.1.351 S trimer are shown in ribbon diagram with the same color scheme as in (A)

of segments (residues 617-644) containing the 630 loop (red) and segments (residues 823-862) containing the FPPR (magenta) from each of the

Bio-layer interferometry (BLI) analysis of the association of prefusion S trimers from the G614 "parent" strain and the B.1.1.7 and B.1.351 variants derived from it with soluble ACE2 constructs and with a panel of antibodies representing five epitopic regions on the RBD and NTD (see Fig. S4A and ref (35)). For ACE2 binding, purified S proteins were immobilized to AR2G biosensors and dipped into the wells containing ACE2 at various concentrations. For antibody binding, various antibodies were immobilized to AHC biosensors and dipped into the wells containing each purified S protein at different concentration. Binding kinetics were evaluated using a 1:1 Langmuir model except for dimeric ACE2 and antibody 32B6 targeting the RBD-2, which were analyzed by a bivalent binding model. The sensorgrams are in black and the fits in red. RU, response unit. Binding constants are also summarized here and in Table S1 . All experiments were repeated at least twice with essentially identical results.